
To analyze the organic indicator for vaccine efficacy in opposition to HPAI H5N1 virus problem of various clades, two inactivated whole-virus H5N1 vaccines containing the hemagglutinin (HA) and neuraminidase (NA) genes of both clade 2.2 A/EM/Korea/W149/06 (RgKoreaW149/06 x PR8) or clade 2.5 A/Ck/Korea/ES/03 (RgKoreaES223N/03XPR8) virus within the background of A/PR/8/34 (H1N1) had been generated by reverse genetics.
Administration of the vaccines (2-dose 1.77, 3.5, 7.5 or 15microg of HA) elicited excessive HI titers in a dose-dependent method. Mice immunized with RgKoreaW149/06 x PR8 had been fully shielded from problem in opposition to wild-type A/EM/Korea/W149/06 with out scientific indicators of an infection. RgKoreaES223N/03XPR8 couldn’t defend mice at 1.77microg whereas all immunized ferrets had been fully protected.
Two-dose (7.5microg) vaccinated mice (HI titer>> or =320) and triple dose (7.5 microg) vaccinated ferrets with RgKoreaES223N/03xPR8 (HI titer>> or =640) protected vaccine recipients from mortality, inhibited nasal virus shedding and restricted influenza virus tropism. Thus, these vaccines offered cross-protectivity in each fashions. Extra importantly, these outcomes collectively advised a optimistic correlation between vaccine-induced HI titers and inhibition of virus shedding together with block of viral proliferation in main organs in opposition to a heterologous HPAI H5N1 virus.
Though creating applied sciences or strategies that may allow the discount of administration dose/frequency stays to be resolved, our research demonstrated a substantial organic marker >> or =640 HI titer) for full safety of the vaccinated hosts that might present a preliminary foundation for the evaluation of full immunization.
Danger components and traits of H5N1 Extremely Pathogenic Avian Influenza (HPAI) post-vaccination outbreaks.
Extremely pathogenic avian influenza (HPAI) virus H5N1 is now endemic in South-East Asia however HPAI management strategies differ between international locations. A widespread HPAI vaccination marketing campaign that began on the finish of 2005 in Viet Nam resulted within the cessation of poultry and human instances, however in 2006/2007 extreme HPAI outbreaks re-emerged. On this research we investigated the sample of this primary post-vaccination epidemic in southern Viet Nam figuring out a spatio-temporal cluster of outbreak incidence and estimating spatially smoothed incidence charges of HPAI.

Spatial danger components related to HPAI incidence had been recognized. Medium-level poultry density resulted in an elevated outbreak danger (Odds ratio (OR) = 5.4, 95% confidence interval (CI): 1.6-18.9) but additionally climate-vegetation components performed an essential position: medium-level normalised distinction vegetation indices through the wet season from Could to October had been related to larger danger of HPAI outbreaks (OR = 3.7, 95% CI: 1.7-8.1), most likely as a result of temporal flooding might need offered appropriate circumstances for the re-emergence of HPAI by increasing the virus distribution within the atmosphere and by enlarging areas of attainable contacts between home waterfowl and wild birds.
Alternatively, a number of agricultural manufacturing components, akin to candy potatoes yield, elevated buffalo density, in addition to elevated electrical energy provide had been related to decreased danger of HPAI outbreaks. This illustrates that preventive management measures for HPAI ought to embody a promotion of low-risk agricultural administration practices in addition to enchancment of the infrastructure in village households. Improved HPAI vaccination efforts and protection ought to deal with medium poultry density areas and on the pre-monsoon time interval.
Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is very immunogenic in Pekin geese challenged with Asian H5N1 HPAI.
The efficacy of various vaccination schedules was evaluated in 17-day-old Pekin geese utilizing an experimental inactivated entire virus vaccine primarily based on the H5N9 A/hen/Italy/22A/98 isolate (H5N9-It) and/or a fowlpox recombinant (vFP-H5) expressing an artificial HA gene from an Asian H5N1 isolate (A/hen/Indonesia/7/2003). Full safety in opposition to scientific indicators and shedding was induced by the totally different vaccination schemes.
Nonetheless, the broadest antibody response and the bottom antibody improve after problem had been noticed within the group of geese whose immune system was primed with the fowlpox vectored vaccine and boosted with the inactivated vaccine, suggesting that this prime-boost technique induced optimum immunity in opposition to H5N1 and minimal viral replication after problem in geese. As well as, this prime-boost vaccination scheme was proven to be immunogenic in 1-day-old ducklings.
A brand new RT-PCR assay particular for influenza A(H2), multiplexed with an assay particular for HPAI A(H5N1).
Worldwide efforts are ongoing to enhance influenza pandemic preparedness, together with from the attitude of the scientific virology laboratory. Particularly, a lot work has been dedicated to the event of diagnostic assays focused on the Extremely Pathogenic Avian Influenza (HPAI) A(H5N1); a lot much less efforts have been dedicated to the A(H2) subtype. But, A(H2) subtype has a confirmed capability to trigger pandemics and is among the many subtypes prioritized for surveillance and management.
PAI 1 antibody |
|||
20R-1823 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal PAI 1 antibody |
PAI 1 Antibody |
|||
ABF5176 | Lifescience Market | 100 ug | EUR 525.6 |
PAI 1 Antibody |
|||
abx216912-100ug | Abbexa | 100 ug | EUR 526.8 |
PAI-1 Antibody |
|||
R34088-100UG | NSJ Bioreagents | 100 ug | EUR 399 |
Pai-1 Antibody |
|||
RQ4041 | NSJ Bioreagents | 100 ug | EUR 419 |
PAI-1 Antibody |
|||
RQ5107 | NSJ Bioreagents | 100ul | EUR 419 |
PAI-1 Antibody |
|||
5579-100 | Biovision | each | EUR 405.6 |
Human PAI 1 ELISA Kit |
|||
EHP0035 | Abclonal | 96Tests | EUR 625.2 |
Human PAI-1 ELISA kit |
|||
LF-EK50581 | Abfrontier | 1×96T | EUR 777.6 |
Recombinant Human PAI-1 Protein |
|||
PROTP05121-2 | BosterBio | 10ug | EUR 380.4 |
Description: Plasminogen Activator Inhibitor-1 (PAI-1, Serpin E1) is a member of the serpin family of serine protease inhibitors, and is the primary inhibitor of urokinase and tissue plasminogen activator (tPA). PAI-1 is expressed predominantly in adipose, liver and vascular tissues, and is also produced by certain tumor cells. Elevated levels of PAI-1 are associated with obesity, diabetes and cardiovascular disease, and increased production of PAI-1 is induced by various obesity related factors such as TNFα, glucose, insulin, and very-low-density lipoprotein. The obesity related elevation of PAI-1 levels along with the consequential deficiency in plasminogen activators can lead directly to increased risk of thrombosis and other coronary diseases. Accordingly, PAI-1 has been implicated as an important molecular link between obesity and coronary disease. PAI-1 can also specifically bind vitronectin (VTN) to form a stable active complex with an increased circulatory half life relative to free PAI-1. Recombinant human PAI-1 is a 42.7 kDa protein containing 379 amino acid residues. |
PAI/ Rat PAI ELISA Kit |
|||
ELA-E0531r | Lifescience Market | 96 Tests | EUR 1063.2 |
Human plasminogen activator inhibitor 1, PAI-1 ELISA Kit |
|||
1-CSB-E07946h | Cusabio |
|
|
Description: Quantitativesandwich ELISA kit for measuring Human plasminogen activator inhibitor 1, PAI-1 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
PAI 1 Blocking Peptide |
|||
AF5176-BP | Affbiotech | 1mg | EUR 234 |
anti- PAI-1 antibody |
|||
FNab06114 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against PAI-1 |
PAI-1 Polyclonal Antibody |
|||
ES3143-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against PAI-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
PAI-1 Polyclonal Antibody |
|||
ES3143-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against PAI-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
PAI-1 Recombinant Protein |
|||
40-126-0002mg | ProSci | 0.002 mg | EUR 311.1 |
Description: Plasminogen Activator Inhibitor-1 (PAI-1, Serpin E1) is a member of the serpin family of serine protease inhibitors, and is the primary inhibitor of urokinase and tissue plasminogen activator (tPA). PAI-1 is expressed predominantly in adipose, liver and vascular tissues, and is also produced by certain tumor cells. Elevated levels of PAI-1 are associated with obesity, diabetes and cardiovascular disease, and increased production of PAI-1 is induced by various obesity related factors such as TNFα, glucose, insulin, and very-low-density lipoprotein. The obesity related elevation of PAI-1 levels along with the consequential deficiency in plasminogen activators can lead directly to increased risk of thrombosis and other coronary diseases. Accordingly, PAI-1 has been implicated as an important molecular link between obesity and coronary disease. PAI-1 can also specifically bind vitronectin (VTN) to form a stable active complex with an increased circulatory half life relative to free PAI-1. Recombinant human PAI-1 is a 42.7 kDa protein containing 379 amino acid residues. |
PAI-1 Recombinant Protein |
|||
40-126-001mg | ProSci | 0.01 mg | EUR 437.1 |
Description: Plasminogen Activator Inhibitor-1 (PAI-1, Serpin E1) is a member of the serpin family of serine protease inhibitors, and is the primary inhibitor of urokinase and tissue plasminogen activator (tPA). PAI-1 is expressed predominantly in adipose, liver and vascular tissues, and is also produced by certain tumor cells. Elevated levels of PAI-1 are associated with obesity, diabetes and cardiovascular disease, and increased production of PAI-1 is induced by various obesity related factors such as TNFα, glucose, insulin, and very-low-density lipoprotein. The obesity related elevation of PAI-1 levels along with the consequential deficiency in plasminogen activators can lead directly to increased risk of thrombosis and other coronary diseases. Accordingly, PAI-1 has been implicated as an important molecular link between obesity and coronary disease. PAI-1 can also specifically bind vitronectin (VTN) to form a stable active complex with an increased circulatory half life relative to free PAI-1. Recombinant human PAI-1 is a 42.7 kDa protein containing 379 amino acid residues. |
PAI-1 Polyclonal Antibody |
|||
41321-100ul | SAB | 100ul | EUR 302.4 |
PAI-1 Polyclonal Antibody |
|||
41321-50ul | SAB | 50ul | EUR 224.4 |
PAI-1 Polyclonal Antibody |
|||
ABP52144-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of PAI-1 from Human, Mouse, Rat. This PAI-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PAI-1 |
PAI-1 Polyclonal Antibody |
|||
ABP52144-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of PAI-1 from Human, Mouse, Rat. This PAI-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PAI-1 |
PAI-1 Polyclonal Antibody |
|||
ABP52144-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of PAI-1 from Human, Mouse, Rat. This PAI-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PAI-1 |
Mouse Pai-1 Antibody |
|||
abx023928-02mg | Abbexa | 0.2 mg | EUR 727.2 |
Recombinant Bovine PAI-1 |
|||
P0141 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Bovine protein for PAI-1 |
Recombinant Mouse PAI-1 |
|||
P0143 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Mouse protein for PAI-1 |
Recombinant Pig PAI-1 |
|||
P0144 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Pig protein for PAI-1 |
Recombinant Rat PAI-1 |
|||
P0145 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Rat protein for PAI-1 |
Anti-PAI-1 antibody |
|||
PAab06114 | Lifescience Market | 100 ug | EUR 463.2 |
Anti-PAI-1 antibody |
|||
STJ16100781 | St John's Laboratory | 100 µg | EUR 724.8 |
Anti-PAI-1 antibody |
|||
STJ94934 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to PAI-1. |
Human PAI-1 PicoKine ELISA Kit |
|||
EK0859 | BosterBio | 96 wells | EUR 547.2 |
Description: For quantitative detection of human PAI-1 in cell culture supernates, cell lysates, serum and plasma(heparin, EDTA, citrate ). |
ELISA kit for Human PAI-1 |
|||
EK5389 | SAB | 96 tests | EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human PAI-1 in samples from serum, plasma, tissue homogenates and other biological fluids. |
PAI-1 ELISA Kit (Human) (OKBB00347) |
|||
OKBB00347 | Aviva Systems Biology | 96 Tests | EUR 652.8 |
Description: Description of target: Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and hence fibrinolysis (the physiological breakdown of blood clots). It is a serine protease inhibitor (serpin) protein (SERPINE1). PAI-1 is mainly produced by the endothelium (cells lining blood vessels), but is also secreted by other tissue types, such as adipose tissue. The PAI-1 gene is located on the seventh chromosome (7q21.3-q22).1 Congenital deficiency of PAI-1 leads to a hemorrhagic diathesis (a tendency to hemorrhage). PAI-1 is present in increased levels in various disease states (such as a number of forms of cancer), as well as in obesity and the metabolic syndrome. It has been linked to the increased occurrence of thrombosis in patients with these conditions. Additionally, it has been shown to interact with ORM1.2 The standard product used in this kit is recombinant human PAI-1 with the molecular mass of 43KDa.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 10 pg/ml |
Human PAI-1 ELISA kit (4X96T) |
|||
LF-EK50582 | Abfrontier | 4×96T | EUR 2641.2 |
Serpin E1/PAI-1, human recombinant |
|||
4731-10 | Biovision | each | EUR 333.6 |
Serpin E1/PAI-1, human recombinant |
|||
4731-100 | Biovision | each | EUR 1286.4 |
Serpin E1/PAI-1, human recombinant |
|||
4731-1000 | Biovision | each | EUR 6637.2 |
Human Glycosylated Ferritin ELISA kit |
|||
E01G0017-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Human Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Glycosylated Ferritin ELISA kit |
|||
E01G0017-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Human Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Glycosylated Ferritin ELISA kit |
|||
E01G0017-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Human Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
PAI antibody |
|||
10R-10324 | Fitzgerald | 100 ug | EUR 522 |
Description: Mouse monoclonal PAI antibody |
Human PAI ELISA Kit |
|||
EHP0600 | Abclonal | 96Tests | EUR 625.2 |
PAI-1 Polyclonal Conjugated Antibody |
|||
C41321 | SAB | 100ul | EUR 476.4 |
Sheep PAI 1 ELISA Kit |
|||
ESP0035 | Abclonal | 96Tests | EUR 625.2 |
Porcine PAI 1 ELISA Kit |
|||
EPP0035 | Abclonal | 96Tests | EUR 625.2 |
Monkey PAI 1 ELISA Kit |
|||
EMKP0035 | Abclonal | 96Tests | EUR 625.2 |
Mouse PAI 1 ELISA Kit |
|||
EMP0035 | Abclonal | 96Tests | EUR 625.2 |
Rat PAI 1 ELISA Kit |
|||
ERP0035 | Abclonal | 96Tests | EUR 625.2 |
Rabbit PAI 1 ELISA Kit |
|||
ERTP0035 | Abclonal | 96Tests | EUR 625.2 |
Monoclonal SERPINE1 / PAI-1 Antibody |
|||
AMR09879G | Leading Biology | 0.05ml | EUR 580.8 |
Description: A Monoclonal antibody against Human SERPINE1 / PAI-1. The antibodies are raised in Mouse. This antibody is applicable in WB and IHC-P, E |
Goat PAI 1 ELISA Kit |
|||
EGTP0035 | Abclonal | 96Tests | EUR 625.2 |
Anserini PAI 1 ELISA Kit |
|||
EAP0035 | Abclonal | 96Tests | EUR 625.2 |
Bovine PAI 1 ELISA Kit |
|||
EBP0035 | Abclonal | 96Tests | EUR 625.2 |
Chicken PAI 1 ELISA Kit |
|||
ECKP0035 | Abclonal | 96Tests | EUR 625.2 |
Canine PAI 1 ELISA Kit |
|||
ECP0035 | Abclonal | 96Tests | EUR 625.2 |
PAI-1 Antibody [Biotin Conjugate] |
|||
R34088BTN | NSJ Bioreagents | 100 ug | EUR 399 |
Plasminogen Activator Inhibitor 1 (PAI-1) |
|||
5-01773 | CHI Scientific | 4 x 5mg | Ask for price |
Human Plasminogen Activator Inhibitor-1 (PAI-1) Antibody |
|||
11501-05011 | AssayPro | 150 ug | EUR 260.4 |
Human PAI-1/Serpin E1 ELISA Kit |
|||
RK00133 | Abclonal | 96 Tests | EUR 625.2 |
Pig plasminogen activator inhibitor 1, PAI-1 ELISA Kit |
|||
1-CSB-E06534p | Cusabio |
|
|
Description: Quantitativesandwich ELISA kit for measuring Pig plasminogen activator inhibitor 1, PAI-1 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Rabbit plasminogen activator inhibitor 1, PAI-1 ELISA Kit |
|||
1-CSB-E06978Rb | Cusabio |
|
|
Description: Quantitativecompetitive ELISA kit for measuring Rabbit plasminogen activator inhibitor 1, PAI-1 in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Mouse plasminogen activator inhibitor 1, PAI-1 ELISA Kit |
|||
1-CSB-E07947m | Cusabio |
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse plasminogen activator inhibitor 1, PAI-1 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Human Glycosylated serum protein ELISA kit |
|||
E01G0373-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Human Glycosylated serum protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Glycosylated serum protein ELISA kit |
|||
E01G0373-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Human Glycosylated serum protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Glycosylated serum protein ELISA kit |
|||
E01G0373-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Human Glycosylated serum protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human glycosylated serum protein ELISA Kit |
|||
ELA-E0998h | Lifescience Market | 96 Tests | EUR 988.8 |
Human Genomic DNA |
|||
X11000 | EpiGentek |
|
|
Human Brain Genomic DNA |
|||
X11001 | EpiGentek |
|
|
PAI 2 Antibody |
|||
AF5174 | Affbiotech | 200ul | EUR 420 |
PAI-3 Antibody |
|||
48021-100ul | SAB | 100ul | EUR 399.6 |
PAI-3 Antibody |
|||
48021-50ul | SAB | 50ul | EUR 286.8 |
PAI-3 Antibody |
|||
abx019149-100ug | Abbexa | 100 ug | EUR 410.4 |
PAI 2 Antibody |
|||
ABF5174 | Lifescience Market | 100 ug | EUR 525.6 |
PAI 2 Antibody |
|||
abx216911-100ug | Abbexa | 100 ug | EUR 526.8 |
Tiplaxtinin(PAI-039) |
|||
B5906-10 | ApexBio | 10 mg | EUR 177.6 |
Description: Description:IC50: 2.7 ?MPlasminogen activator inhibitor-1 (PAI-1) is the most important physiologic regulator of the plasminogen activation system through its inhibition of its target serine proteases, tissue plasminogen activator, and urokinase plasminogen activator. |
Tiplaxtinin(PAI-039) |
|||
B5906-5 | ApexBio | 5 mg | EUR 157.2 |
Description: Description:IC50: 2.7 ?MPlasminogen activator inhibitor-1 (PAI-1) is the most important physiologic regulator of the plasminogen activation system through its inhibition of its target serine proteases, tissue plasminogen activator, and urokinase plasminogen activator. |
Tiplaxtinin(PAI-039) |
|||
B5906-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 199.2 |
Description: Description:IC50: 2.7 ?MPlasminogen activator inhibitor-1 (PAI-1) is the most important physiologic regulator of the plasminogen activation system through its inhibition of its target serine proteases, tissue plasminogen activator, and urokinase plasminogen activator. |
Tiplaxtinin(PAI-039) |
|||
B5906-50 | ApexBio | 50 mg | EUR 505.2 |
Description: Description:IC50: 2.7 ?MPlasminogen activator inhibitor-1 (PAI-1) is the most important physiologic regulator of the plasminogen activation system through its inhibition of its target serine proteases, tissue plasminogen activator, and urokinase plasminogen activator. |
Human plasminogen activator inhibitor 1, PAI-1 ELISA Kit |
|||
CSB-E07946h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
Description: Quantitativesandwich ELISA kit for measuring Human plasminogen activator inhibitor 1, PAI-1 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human plasminogen activator inhibitor 1,PAI-1 ELISA kit |
|||
E01P0889-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Human plasminogen activator inhibitor 1,PAI-1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human plasminogen activator inhibitor 1,PAI-1 ELISA kit |
|||
E01P0889-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Human plasminogen activator inhibitor 1,PAI-1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human plasminogen activator inhibitor 1,PAI-1 ELISA kit |
|||
E01P0889-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Human plasminogen activator inhibitor 1,PAI-1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human plasminogen activator inhibitor 1,PAI-1 ELISA Kit |
|||
201-12-1160 | SunredBio | 96 tests | EUR 528 |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human plasminogen activator inhibitor 1(PAI-1)ELISA Kit |
|||
GA-E1176HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human plasminogen activator inhibitor 1(PAI-1)ELISA Kit |
|||
GA-E1176HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
Human plasminogen activator inhibitor 1(PAI-1)ELISA Kit |
|||
QY-E00912 | Qayee Biotechnology | 96T | EUR 433.2 |
Human plasminogen activator inhibitor 1,PAI-1 ELISA Kit |
|||
YLA0869HU-48T | Shanghai YL Biotech | 48T | EUR 435 |
Human plasminogen activator inhibitor 1,PAI-1 ELISA Kit |
|||
YLA0869HU-96T | Shanghai YL Biotech | 96T | EUR 562.5 |
Recombinant Human PAI-2 Protein |
|||
PROTP05120-2 | BosterBio | 10ug | EUR 380.4 |
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein. |
Plasminogen Activator Inhibitor 1 (PAI-1) Antibody |
|||
20-abx001181 | Abbexa |
|
|
Plasminogen Activator Inhibitor 1 (PAI-1) Antibody |
|||
abx022412-02mg | Abbexa | 0.2 mg | EUR 861.6 |
Plasminogen Activator Inhibitor 1 (PAI-1) Antibody |
|||
abx023283-02mg | Abbexa | 0.2 mg | EUR 861.6 |
Plasminogen Activator Inhibitor 1 (PAI-1) Antibody |
|||
abx024067-200ug | Abbexa | 200 ug | EUR 693.6 |
Plasminogen Activator Inhibitor 1 (PAI-1) Peptide |
|||
20-abx266356 | Abbexa |
|
|
Plasminogen Activator Inhibitor 1 (PAI-1) Antibody |
|||
abx236114-100ug | Abbexa | 100 ug | EUR 610.8 |
Polyclonal SERPINE1 / PAI-1 Antibody (Internal) |
|||
AMR09881G | Leading Biology | 0.05mg | EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human SERPINE1 / PAI-1 (Internal). This antibody is tested and proven to work in the following applications: |
Guinea Pig PAI 1 ELISA Kit |
|||
EGP0035 | Abclonal | 96Tests | EUR 625.2 |
Recombinant Human Serpin E1/PAI-1 (C-6His) |
|||
C537-10ug | Novoprotein | 10ug | EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM HAc-NaAc, 150mM NaCl, pH 4.0. |
Recombinant Human Serpin E1/PAI-1 (C-6His) |
|||
C537-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM HAc-NaAc, 150mM NaCl, pH 4.0. |
Recombinant Human Serpin E1/PAI-1 (C-6His) |
|||
C537-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM HAc-NaAc, 150mM NaCl, pH 4.0. |
Recombinant Human Serpin E1/PAI-1 (C-6His) |
|||
C537-50ug | Novoprotein | 50ug | EUR 595.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM HAc-NaAc, 150mM NaCl, pH 4.0. |
PAI-1 ELISA Kit (Human) : 96 Wells (OKAG00055) |
|||
OKAG00055 | Aviva Systems Biology | 96 Wells | EUR 715.2 |
Description: Description of target: This gene encodes a member of the serine proteinase inhibitor (serpin) superfamily. This member is the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), and hence is an inhibitor of fibrinolysis. Defects in this gene are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency), and high concentrations of the gene product are associated with thrombophilia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.;Species reactivity: Human;Application: ELISA;Assay info: Quantitative Colorimentric Sandwich ELISA;Sensitivity: 23 pg/mL |
Goat Glycosylated Ferritin ELISA kit |
|||
E06G0017-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Goat Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Glycosylated Ferritin ELISA kit |
|||
E06G0017-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Goat Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Glycosylated Ferritin ELISA kit |
|||
E06G0017-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Goat Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Glycosylated Ferritin ELISA kit |
|||
E02G0017-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Rat Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Glycosylated Ferritin ELISA kit |
|||
E02G0017-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Rat Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Glycosylated Ferritin ELISA kit |
|||
E02G0017-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Rat Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Glycosylated Ferritin ELISA kit |
|||
E04G0017-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Rabbit Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Glycosylated Ferritin ELISA kit |
|||
E04G0017-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Rabbit Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Glycosylated Ferritin ELISA kit |
|||
E04G0017-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Rabbit Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Glycosylated Ferritin ELISA kit |
|||
E08G0017-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Canine Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Glycosylated Ferritin ELISA kit |
|||
E08G0017-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Canine Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Glycosylated Ferritin ELISA kit |
|||
E08G0017-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Canine Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Glycosylated Ferritin ELISA kit |
|||
E03G0017-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Mouse Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Glycosylated Ferritin ELISA kit |
|||
E03G0017-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Mouse Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Glycosylated Ferritin ELISA kit |
|||
E03G0017-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Mouse Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Glycosylated Ferritin ELISA kit |
|||
E07G0017-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Porcine Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Glycosylated Ferritin ELISA kit |
|||
E07G0017-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Porcine Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Glycosylated Ferritin ELISA kit |
|||
E07G0017-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Porcine Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Glycosylated Ferritin ELISA kit |
|||
E09G0017-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Monkey Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Glycosylated Ferritin ELISA kit |
|||
E09G0017-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Monkey Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Glycosylated Ferritin ELISA kit |
|||
E09G0017-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Monkey Glycosylated Ferritin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human HbA1c/ Glycosylated hemoglobin A1c ELISA Kit |
|||
E1095Hu | Sunlong | 1 Kit | EUR 685.2 |
ELISA kit for Human Glycosylated hemoglobin A1c |
|||
EK2419 | SAB | 96 tests | EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Glycosylated hemoglobin A1c in samples from serum, plasma, tissue homogenates and other biological fluids. |
Human GSP(Glycosylated Serum Protein) ELISA Kit |
|||
EH3187 | FN Test | 96T | EUR 628.92 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 46.875nmol/ml |
Human glycosylated serum protein,GSP ELISA Kit |
|||
201-12-0031 | SunredBio | 96 tests | EUR 528 |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Glycosylated Serum Protein (GSP) CLIA Kit |
|||
abx197056-96tests | Abbexa | 96 tests | EUR 990 |
Human Glycosylated Serum Protein (GSP) ELISA Kit |
|||
abx252587-96tests | Abbexa | 96 tests | EUR 904.8 |
Human HbA1c(Glycosylated hemoglobin A1c) ELISA Kit |
|||
EH0457 | FN Test | 96T | EUR 628.92 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 1.875 ng/ml |
Human Glycosylated hemoglobin A1c, HbA1c ELISA KIT |
|||
ELI-03014h | Lifescience Market | 96 Tests | EUR 988.8 |
Human glycosylated serum protein(GSP)ELISA Kit |
|||
GA-E0041HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human glycosylated serum protein(GSP)ELISA Kit |
|||
GA-E0041HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
Human glycosylated serum protein(GSP)ELISA Kit |
|||
QY-E01291 | Qayee Biotechnology | 96T | EUR 433.2 |
Human glycosylated serum protein,GSP ELISA Kit |
|||
YLA0204HU-48T | Shanghai YL Biotech | 48T | EUR 435 |
Human glycosylated serum protein,GSP ELISA Kit |
|||
YLA0204HU-96T | Shanghai YL Biotech | 96T | EUR 562.5 |
Human Plasminogen Activator Inhibitor-1 (PAI-1) Antibody (Biotin Conjugate) |
|||
11501-05021 | AssayPro | 150 ug | EUR 331.2 |
Nori® Human Serpin E1/PAI-1 ELISA Kit |
|||
GR111106 | Genorise Scientific | 96-well | EUR 553.2 |
Recombinant Human SerpinE1/ PAI-1 Protein, His, E.coli-100ug |
|||
QP8711-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human SerpinE1/ PAI-1 Protein, His, E.coli-10ug |
|||
QP8711-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human SerpinE1/ PAI-1 Protein, His, E.coli-1mg |
|||
QP8711-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human SerpinE1/ PAI-1 Protein, His, E.coli-200ug |
|||
QP8711-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human SerpinE1/ PAI-1 Protein, His, E.coli-500ug |
|||
QP8711-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human SerpinE1/ PAI-1 Protein, His, E.coli-50ug |
|||
QP8711-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Nori® Rabbit Pai-1 ELISA Kit |
|||
GR144022 | Genorise Scientific | 96-well | EUR 553.2 |
PAI 2 Blocking Peptide |
|||
AF5174-BP | Affbiotech | 1mg | EUR 234 |
PAI-3 Conjugated Antibody |
|||
C48021 | SAB | 100ul | EUR 476.4 |
Sheep PAI ELISA Kit |
|||
ESP0600 | Abclonal | 96Tests | EUR 625.2 |
PAI-3 Polyclonal Antibody |
|||
ES3144-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against PAI-3 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
PAI-3 Polyclonal Antibody |
|||
ES3144-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against PAI-3 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
PAI-2 Polyclonal Antibody |
|||
ES6455-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against PAI-2 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
PAI-2 Polyclonal Antibody |
|||
ES6455-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against PAI-2 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Porcine PAI ELISA Kit |
|||
EPP0600 | Abclonal | 96Tests | EUR 625.2 |
Monkey PAI ELISA Kit |
|||
EMKP0600 | Abclonal | 96Tests | EUR 625.2 |
Mouse PAI ELISA Kit |
|||
EMP0600 | Abclonal | 96Tests | EUR 625.2 |
Rat PAI ELISA Kit |
|||
ERP0600 | Abclonal | 96Tests | EUR 625.2 |
Rabbit PAI ELISA Kit |
|||
ERTP0600 | Abclonal | 96Tests | EUR 625.2 |
PAI-2 Recombinant Protein |
|||
40-127-0002mg | ProSci | 0.002 mg | EUR 311.1 |
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/mL), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein. |
PAI-2 Recombinant Protein |
|||
40-127-001mg | ProSci | 0.01 mg | EUR 437.1 |
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/mL), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein. |
PAI-2 Polyclonal Antibody |
|||
ABP55456-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of PAI-2 from Human. This PAI-2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PAI-2 |
PAI-2 Polyclonal Antibody |
|||
ABP55456-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of PAI-2 from Human. This PAI-2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PAI-2 |
PAI-2 Polyclonal Antibody |
|||
ABP55456-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of PAI-2 from Human. This PAI-2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PAI-2 |
PAI-3 Polyclonal Antibody |
|||
ABP52145-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of PAI-3 from Human. This PAI-3 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PAI-3 at AA range: 230-310 |
PAI-3 Polyclonal Antibody |
|||
ABP52145-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of PAI-3 from Human. This PAI-3 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PAI-3 at AA range: 230-310 |
PAI-3 Polyclonal Antibody |
|||
ABP52145-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of PAI-3 from Human. This PAI-3 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human PAI-3 at AA range: 230-310 |
Though the human A(H2N2) virus that triggered the pandemic of 1957 now not circulates, many associated avian A(H2) viruses flow into in avian inhabitants and will conceivably adapt to contaminate people and trigger a brand new pandemic. On this research the design and improvement of an RT-PCR assay particular for A(H2) subtype is offered. It’s proven that the assay is very delicate and particular, in a position to detect human and avian A(H2) viruses, and will be included right into a multiplex assay with one other beforehand described assay for HPAI A(H5N1).